Last reviewed · How we verify
Lower urinary tract infectious disease
Approved treatments
- PRULIFLOXACIN
Prulifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Lower urinary tract infectious disease patent landscape — cliff calendar, originator estates, attackable patents
- Lower urinary tract infectious disease treatment landscape brief
- Lower urinary tract infectious disease treatment updates RSS
Frequently asked questions about Lower urinary tract infectious disease
What drugs treat Lower urinary tract infectious disease?
Tracked treatments include PRULIFLOXACIN.
What is the treatment for Lower urinary tract infectious disease?
Standard treatment for Lower urinary tract infectious disease includes PRULIFLOXACIN. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Lower urinary tract infectious disease patent cliff · Lower urinary tract infectious disease CI report
- Treatment: PRULIFLOXACIN
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing